These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 29468984)
21. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of dementia. Santaguida PS; Raina P; Booker L; Patterson C; Baldassarre F; Cowan D; Gauld M; Levine M; Unsal A Evid Rep Technol Assess (Summ); 2004 Apr; (97):1-16. PubMed ID: 15279402 [No Abstract] [Full Text] [Related]
23. Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment. Smith EE; Cieslak A; Barber P; Chen J; Chen YW; Donnini I; Edwards JD; Frayne R; Field TS; Hegedus J; Hanganu V; Ismail Z; Kanji J; Nakajima M; Noor R; Peca S; Sahlas D; Sharma M; Sposato LA; Swartz RH; Zerna C; Black SE; Hachinski V J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28476873 [No Abstract] [Full Text] [Related]
24. (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Li W; Liu H; Jiang H; Wang C; Guo Y; Sun Y; Zhao X; Xiong X; Zhang X; Zhang K; Nie Z; Pu X Sci Rep; 2017 Aug; 7(1):10052. PubMed ID: 28855592 [TBL] [Abstract][Full Text] [Related]
25. Pathology and pathophysiology of vascular cognitive impairment. A critical update. Jellinger KA Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978 [TBL] [Abstract][Full Text] [Related]
26. [Influence of aniracetam on the learning ability, memory ability and the expression of BCL-2 of hippocampal in vascular dementia model rats]. Pan Y; Dai T; Yang Q Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):180-1, 227. PubMed ID: 21189545 [No Abstract] [Full Text] [Related]
27. Chotosan ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia via activating the Nrf2-mediated antioxidant pathway. Jiang P; Chen L; Sun J; Li J; Xu J; Liu W; Feng F; Qu W J Pharmacol Sci; 2019 Feb; 139(2):105-111. PubMed ID: 30642751 [TBL] [Abstract][Full Text] [Related]
28. Facts, myths, and controversies in vascular dementia. Román GC J Neurol Sci; 2004 Nov; 226(1-2):49-52. PubMed ID: 15537519 [TBL] [Abstract][Full Text] [Related]
29. Hydroxysafflor yellow A increases BDNF and NMDARs in the hippocampus in a vascular dementia rat model. Xing M; Sun Q; Wang Y; Cheng Y; Zhang N Brain Res; 2016 Jul; 1642():419-425. PubMed ID: 27086971 [TBL] [Abstract][Full Text] [Related]
30. Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. Xu QQ; Shan CS; Wang Y; Shi YH; Zhang QH; Zheng GQ J Alzheimers Dis; 2018; 62(1):429-456. PubMed ID: 29439346 [TBL] [Abstract][Full Text] [Related]
31. Lokomat training in vascular dementia: motor improvement and beyond! Calabrò RS; De Luca R; Leo A; Balletta T; Marra A; Bramanti P Aging Clin Exp Res; 2015 Dec; 27(6):935-7. PubMed ID: 25762160 [TBL] [Abstract][Full Text] [Related]
32. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. Pantoni L J Neurol Sci; 2004 Nov; 226(1-2):67-70. PubMed ID: 15537523 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of dementia: a scoping review of systematic reviews. van de Glind EM; van Enst WA; van Munster BC; Olde Rikkert MG; Scheltens P; Scholten RJ; Hooft L Dement Geriatr Cogn Disord; 2013; 36(3-4):211-28. PubMed ID: 23941762 [TBL] [Abstract][Full Text] [Related]
34. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation. Lanza G; Bramanti P; Cantone M; Pennisi M; Pennisi G; Bella R Behav Neurol; 2017; 2017():1421326. PubMed ID: 28348458 [TBL] [Abstract][Full Text] [Related]
35. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable? Kim JM; Lyons D; Shin IS; Yoon JS Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174 [TBL] [Abstract][Full Text] [Related]
36. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
37. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia. Wan L; Cheng Y; Luo Z; Guo H; Zhao W; Gu Q; Yang X; Xu J; Bei W; Guo J J Ethnopharmacol; 2015 May; 165():118-26. PubMed ID: 25704930 [TBL] [Abstract][Full Text] [Related]
38. Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan. Xu X; Zhang B; Lu K; Deng J; Zhao F; Zhao BQ; Zhao Y Mol Neurobiol; 2016 Jul; 53(5):3494-3502. PubMed ID: 26887382 [TBL] [Abstract][Full Text] [Related]
39. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study. Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815 [TBL] [Abstract][Full Text] [Related]
40. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]